RUSSELL JACKSON: Open Payments
NPI 1699322578 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 70 payments from 19 companies in 2025. Trend: 2023 $195 · 2024 $175 · 2025 $836
Food & beverage: $816Education: $20
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 26 | $169 |
| Bayer Healthcare Pharmaceuticals Inc. | 19 | $169 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Novo Nordisk Inc | 4 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Abbott Laboratories | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Ardelyx, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
Products named: Kerendia, OTEZLA, GEMTESA, CAPLYTA, Ozempic, REXULTI, Rybelsus, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
